Researchers identified 20 drug candidates that reduce C4 immune protein secretion from astrocytes. The discovery could pave the way to treating schizophrenia and other disorders associated with C4 dysregulation in astrocytes.
The risk of developing Alzheimer's disease and dementia-related symptoms is higher in those with TBI and PTSD who carry the APOE E4 gene.
Researchers have developed a new treatment that could potentially be used to treat patients with the Phelan-McDermid syndrome autism subtype.
A new model of autism development gives insights into how various risk factors give rise to ASD symptoms and why there is such great variability between individuals.
Researchers used innovative recording technology to show human brain organoids transplanted into mice establish functional connectivity in the cortex and respond to visual stimuli.
2022 has been a fantastic year for neuroscience and brain science research. Here, we take a look back over some of the most popular neuroscience research articles of the year.
Autopsy tissue samples of 44 people who died of COVID-19 showed SAR-CoV-2, the virus responsible for coronavirus, spread throughout the body and to the brain, with traces of the virus lingering for 8 months.
Those who suffer from dry eye disease are at greater risk of suffering injuries to their corneas. Researchers report proteins produced by stem cells that regenerate the cornea could be targeted to treat or prevent such injuries.
A newly designed method can record gene activity patterns and the presence of key proteins in cells across tissue samples while retaining information about the cell's precise location.
More severe COVID-19 outcomes associated with age-related macular degeneration likely arise from a genetic predisposition in addition to higher levels of Pdgf in blood serum.
A new stem cell therapy approach eliminates established brain tumors and provides long-term immunity, training the immune system to prevent cancer from returning.
Lab-created retinal cells created from human stem cells can reach out and connect to neighboring cells, a new study reports. The cells have the capacity to replace damaged retinal cells and carry sensory information. The findings could pave the way for clinical trials for the treatment of a range of diseases associated with vision loss and blindness.
